Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
17.64
-0.78 (-4.23%)
At close: Dec 5, 2025, 4:00 PM EST
17.59
-0.05 (-0.28%)
After-hours: Dec 5, 2025, 7:59 PM EST
Schrödinger Revenue
Schrödinger had revenue of $54.32M in the quarter ending September 30, 2025, with 53.94% growth. This brings the company's revenue in the last twelve months to $256.95M, up 32.90% year-over-year. In the year 2024, Schrödinger had annual revenue of $207.54M, down -4.21%.
Revenue (ttm)
$256.95M
Revenue Growth
+32.90%
P/S Ratio
5.03
Revenue / Employee
$288,385
Employees
891
Market Cap
1.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 207.54M | -9.13M | -4.21% |
| Dec 31, 2023 | 216.67M | 35.71M | 19.73% |
| Dec 31, 2022 | 180.96M | 43.02M | 31.19% |
| Dec 31, 2021 | 137.93M | 29.84M | 27.60% |
| Dec 31, 2020 | 108.10M | 22.55M | 26.36% |
| Dec 31, 2019 | 85.54M | 18.90M | 28.37% |
| Dec 31, 2018 | 66.64M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SDGR News
- 4 days ago - Unlocking Hidden Value In Schrodinger's Box - Seeking Alpha
- 4 weeks ago - Schrödinger to Present at Jefferies London Healthcare Conference - Business Wire
- 4 weeks ago - Schrödinger, Inc. (SDGR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Schrödinger Reports Third Quarter 2025 Financial Results - Business Wire
- 5 weeks ago - Copernic Catalysts Announces Achievement of Ammonia Catalyst Milestone in Research Collaboration with Schrödinger - Business Wire
- 6 weeks ago - Schrödinger to Announce Third Quarter 2025 Financial Results on November 5 - Business Wire
- 7 weeks ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Schrödinger, Inc. (SDGR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha